国际泌尿系统杂志
國際泌尿繫統雜誌
국제비뇨계통잡지
International Journal of Urology and Nephrology
2015年
5期
703-705
,共3页
茅原申%陆超%李文峰%顾欣%潘惟昕%顾豫飞%张士青
茅原申%陸超%李文峰%顧訢%潘惟昕%顧豫飛%張士青
모원신%륙초%리문봉%고흔%반유흔%고예비%장사청
受体,肾上腺素能α1%输尿管结石
受體,腎上腺素能α1%輸尿管結石
수체,신상선소능α1%수뇨관결석
Receptors,Adrenergic,alpha-1%Ureteral Calculi
目的 评估α1受体阻滞剂及消脱止-M在防治双J管相关症状的作用.方法 制定纳入与排除标准,将符合纳入标准的105例输尿管镜激光碎石术后患者随机分成对照组(n=35),α1受体阻滞剂组(n=36),消脱止-M组(n=34).对照组术后不做任何药物干预;其余两组每天分别口服α1受体阻滞剂组(盐酸坦洛新缓释片,0.2mg,每晚一次)、消脱止-M(500mg,一天3次,一次两粒),3组患者均在第二周末拔除体内双J管,拔管前完成IPSS症状学评分、长海痛尺疼痛评分问卷检查及尿常规检查.结果 3组患者术前一般情况差异无统计学意义.α1受体阻滞剂组及消脱止-M组在IPSS症状学评分、疼痛评分要明显优于对照组(P<0.05),但两者间无明显差异.两实验组的血尿程度明显低于对照组(P<0.05),且消脱止-M组血尿程度明显低于α1受体阻滞剂组(P<0.05).结论 α1受体阻滞剂和消脱止-M在减轻输尿管镜激光碎石后双J管相关症状中均有明显作用,消脱止-M减轻血尿效果优于α1受体阻滞剂.
目的 評估α1受體阻滯劑及消脫止-M在防治雙J管相關癥狀的作用.方法 製定納入與排除標準,將符閤納入標準的105例輸尿管鏡激光碎石術後患者隨機分成對照組(n=35),α1受體阻滯劑組(n=36),消脫止-M組(n=34).對照組術後不做任何藥物榦預;其餘兩組每天分彆口服α1受體阻滯劑組(鹽痠坦洛新緩釋片,0.2mg,每晚一次)、消脫止-M(500mg,一天3次,一次兩粒),3組患者均在第二週末拔除體內雙J管,拔管前完成IPSS癥狀學評分、長海痛呎疼痛評分問捲檢查及尿常規檢查.結果 3組患者術前一般情況差異無統計學意義.α1受體阻滯劑組及消脫止-M組在IPSS癥狀學評分、疼痛評分要明顯優于對照組(P<0.05),但兩者間無明顯差異.兩實驗組的血尿程度明顯低于對照組(P<0.05),且消脫止-M組血尿程度明顯低于α1受體阻滯劑組(P<0.05).結論 α1受體阻滯劑和消脫止-M在減輕輸尿管鏡激光碎石後雙J管相關癥狀中均有明顯作用,消脫止-M減輕血尿效果優于α1受體阻滯劑.
목적 평고α1수체조체제급소탈지-M재방치쌍J관상관증상적작용.방법 제정납입여배제표준,장부합납입표준적105례수뇨관경격광쇄석술후환자수궤분성대조조(n=35),α1수체조체제조(n=36),소탈지-M조(n=34).대조조술후불주임하약물간예;기여량조매천분별구복α1수체조체제조(염산탄락신완석편,0.2mg,매만일차)、소탈지-M(500mg,일천3차,일차량립),3조환자균재제이주말발제체내쌍J관,발관전완성IPSS증상학평분、장해통척동통평분문권검사급뇨상규검사.결과 3조환자술전일반정황차이무통계학의의.α1수체조체제조급소탈지-M조재IPSS증상학평분、동통평분요명현우우대조조(P<0.05),단량자간무명현차이.량실험조적혈뇨정도명현저우대조조(P<0.05),차소탈지-M조혈뇨정도명현저우α1수체조체제조(P<0.05).결론 α1수체조체제화소탈지-M재감경수뇨관경격광쇄석후쌍J관상관증상중균유명현작용,소탈지-M감경혈뇨효과우우α1수체조체제.
Objectives To evaluate the tamsulosin and melilotus extract tablets in improving double-J stent related urinary tract symptom.Methods Formulate the included and excluded standards,105 patients who fit the included standards with double-J stent placement following ureteroscopic lithotripsy randomize into three groups,the control group(n =35),the alpha1-receptor blockers group(n =36) and the melilotus group(n =34).The control group have regular treatment.The other two groups respectively received tamsulosin 0.2mg once daily and melilotus extract tablets 1000mg t.i.d.All patients removed double-J stent in two weeks,and completed the questionnaire(compare IPSS symptoms scores,Changhai pain rating scale for pain assessmentand urine routine examination) before patients removing double-J stent to measure the degree of hematuria.Results No statistical significance between three groups before the surgery.The IPSS,pain scale and the degree of hematuria in the alpha1-receptor blockers group and the melilotus group is significantly better than the control group(P < 0.05),but no significant differences between the alpha1-receptor blockers group and the melilotus group.The degree of hematuria in two experiment groups is significantly lower than the control group,and the degree of hematuria in the melilotus group is significantly lower than the alpha1-receptor blockers group(P < 0.05).Conclusions Tamsulosin and melilotus extract tablets both can improve double-J stent related urinary tract symptom,and the melilotus is better than the tamsulosin in the aspect of reducing the degree of hematuria.